This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

The Latest Version Of Operetta's Software, Harmony 3.5, Enables Scientists To Track Individual Cells Over Time For A Better Understanding Of Dynamic Processes And To Generate More Accurate Prediction Models. (Photo: Business Wire)

PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, has announced enhancements for its Operetta ® High Content Imaging System, designed to significantly improve the ability of scientists to perform live cell assays with higher throughput, to help foster a better understanding of normal and aberrant cellular behavior.

The latest version of Operetta's software, Harmony 3.5, enables scientists to track individual cells ...

The latest version of Operetta's software, Harmony 3.5, enables scientists to track individual cells over time for a better understanding of dynamic processes and to generate more accurate prediction models. (Photo: Business Wire)

Scientists conducting research in the areas of cancer, stem cells or infectious diseases will benefit from the Operetta system’s new capabilities to analyze the dynamic behavior of cells using advanced live cell, high content imaging. With the new capabilities, users will be able to accurately observe individual cell behavior over time to better understand dynamic processes in order to generate more accurate prediction models, for example how cancer cells migrate during metastasis or how viruses invade cells.

“We are seeing a trend towards researchers using biological assays that are better models of the physiological environment in vivo earlier in the drug discovery process in order to improve the likelihood of a drug succeeding at clinical trial.” said Jim Corbett, President, Diagnostics and Life Sciences, PerkinElmer. “With these new live cell imaging capabilities, our customers will have easy access to a wider range of applications than ever before and will be able to generate more biologically relevant data on how cells respond to compounds, helping to reduce false positives later in the drug discovery process.”

The Operetta system’s new capabilities include brightfield imaging and environmental chamber options, and a new transmitted light digital phase-contrast mode that enables users to image and segment live cells without using fluorescent dyes. This feature reduces toxic effects of nuclear stains that may negatively impact the viability of cells, enabling longer and more predictive live cell studies. Furthermore, it can help to reduce assay costs.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,098.45 +18.88 0.11%
S&P 500 2,003.37 +6.63 0.33%
NASDAQ 4,580.2710 +22.5760 0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs